The role of procalcitonin and N-terminal pro-B-type natriuretic peptide in predicting outcome after cardiac surgery

Perfusion (United Kingdom)

Volumn 27, Issue 6, 2012, Pages 504-511

  Kallel, S ^a   Jmel, W ^a   Jarraya, A ^a   Abdenadher, M ^a   Frikha, I ^a   Karouia, A ^a  

^a Academic Medical Center Habib Bourguiba   (Tunisia)

Author keywords

heart surgery; ICU stay; pro brain natriuretic peptide; procalcitonin; severe SIRS

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CORONARY ARTERY SURGERY; DISEASE SEVERITY; ELECTIVE SURGERY; FEMALE; HEART VALVE SURGERY; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

BIOLOGICAL MARKERS; CALCITONIN; CARDIAC SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROTEIN PRECURSORS; TREATMENT OUTCOME;

EID: 84868130374     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659112454155     Document Type: Review

References (35)

1. Aouifi A, Piriou V, Blanc P, et al. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anesth. 1999 ; 83: 602-607
2. Kerbaul F, Guidon C, Lejeune PJ, Mollo M, Mesana T, Gouin F. Hyperprocalcitonemia is related to postoperative severe SIRS associated with coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 2002 ; 16: 47-53
3. Wan S, Leclerc JL, Vincent JL. Inflammatory response to cardiopulmonary bypass. Mechanisms involved and possible therapeutic strategies. Chest. 1997 ; 112: 676-692
4. Fransen E, Messen J, Dentener M, Senden N, Geskes G, Buurman W. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest. 1998 ; 111: 1290-1295
5. Menasché P. The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function. Curr Opin Cardiol. 1995 ; 10: 604
6. Fagon JY, Chastre A, Novara P, Medioni Gilbert C. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: the ODIN model. Intensive Care Med. 1993 ; 19: 137-144
7. de Lemos JA, Morrow DA. Brain natriuretic peptide in acute coronary syndromes. Ready for clinical application?. Circulation. 2002 ; 106: 2868-2870
8. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Eng J Med. 2002 ; 345: 1014-1021
9. Selvais PL, Donckier JE, Robert A, et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influence of left ventricular dysfunction and coronary artery diseases on cardiac hormonal activation. Eur J Clin Invest. 1998 ; 28: 636-642
10. Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J. 2002 ; 144: 834-839
11. Hutfless R, Kazanegra R, Madani M, et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol. 2004 ; 43 (10). 1873-1879
12. Provenchère S, Berroeta C, Reynaud C, et al. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med. 2006 ; 34: 995-1000
13. Jacobs JW, Lund PK, Potts JT, Bell HH, Habener JF. Procalcitonin is a glycoprotein. J Biol Chem. 1981 ; 256: 2803-2807
14. Harbarth S, Holeckova K, Froidevaux C, et al. Geneva Sepsis Network: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001 ; 164: 396-402
15. Cleys R, Vinken S, Spapen H, et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med. 2002 ; 30: 758-762
16. Lecharny JB, Khater D, Bronchard R, et al. Hyper procalcitonemia in patients with perioperative myocardial infarction after cardiac surgery. Crit Care Med. 2001 ; 29: 323-325
17. Dorge H, Schondube FA, Dorge P, Seipelt R, Voss M, Messmer BJ. Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection. Thorac Cardiovasc Surg. 2003 ; 51: 322-326
18. Sponholz C, Sakr Y, Reinhart K, Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care. 2006 ; 10: R145
19. Kilger E, Pichler B, Goetz E, et al. Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting. Thorac Cardiovasc Surg. 1998 ; 46: 130-133
20. Cremer J, Martin M, Redl H, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg. 1996 ; 61: 1714-1720
21. Hall RI, Stafford Smith M, Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic and pharmacological considerations. Anesth Analg. 1997 ; 85: 766-782
22. Messent M, Sullvan K, Keogh BF, Morgan CJ, Evans TW. Adult respiratory distress syndrome following cardiopulmonary bypass: incidence and prediction. Anesthesia. 1992 ; 47: 267-268
23. Menasché P. The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function. Curr Opin Cardiol. 1995 ; 10: 597-604
24. Hensel M, Volk T, Docke WD, et al. Hyperprocalcitonemia in patients with SIRS and pulmonary dysfunction associated with cardiopulmonary bypass. Anesthesiology. 1988 ; 89: 93-104
25. Boeken U, Feindt P, Micek M, Petzold T, Schulte HD, Gams E. Procalcitonin (PCT) in cardiac surgery: diagnostic value in systemic inflammatory response syndrome (SIRS), sepsis and after heart transplantation (HTX). Cardiovasc Surg. 2000 ; 8: 550-554
26. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. The Lancet. 1993 ; 341: 515-518
27. Ugarte H, Silva E, Mercan D, De Mendonc A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med. 1999 ; 27: 498-504
28. Carsin H, Assicot M, Feger F, et al. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF alpha and endotoxin levels early after thermal injury. Burns. 1997 ; 23: 218-224
29. Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 1998 ; 24: 185-188
30. Meisner M, Rauschmayer C, Schmidt J, et al. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med. 2002 ; 28: 1094-1102
31. Selvais PL, Donckier JE, Robert A, et al. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influence of left ventricular dysfunction and coronary artery diseases on cardiac hormonal activation. Eur J Clin Invest. 1998 ; 28: 636-642
32. Wieczorek SJ, Wu AH, Christenson R, et al. A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J. 2002 ; 144: 834-839
33. Nakao K, Mukoyama M, Hosoda K, et al. Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide. Can J Physiol Pharmacol. 1991 ; 69: 1500-1506
34. Kilger E, Pichler B, Goetz E, et al. Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting. Thorac Cardiovasc Surg. 1998 ; 46: 130-133
35. Crescenzi G, Landoni G, Bignami E, et al. N-terminal B-natriuretic peptide after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2009 ; 23: 147-150